Loading…

Comparison of analytical sensitivity of SARS-CoV-2 molecular detection kits

•This study is the first to evaluate other molecular detection assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as rRT-PCR detection kits.•This is the most comprehensive evaluation of currently approved National Medical Products Administration detection kits.•Factors...

Full description

Saved in:
Bibliographic Details
Published in:International journal of infectious diseases 2021-10, Vol.111, p.233-241
Main Authors: Yang, Jing, Han, Yanxi, Zhang, Runling, Zhang, Rui, Li, Jinming
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•This study is the first to evaluate other molecular detection assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as rRT-PCR detection kits.•This is the most comprehensive evaluation of currently approved National Medical Products Administration detection kits.•Factors that may affect the sensitivity of the detection process were analyzed comprehensively. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has had a significant impact on global public health systems, making nucleic acid detection an important tool in epidemic prevention and control. Detection kits based on real-time reverse transcriptase PCR (rRT-PCR) have been used widely in clinics, but their analytical sensitivity (limit of detection, LOD) remains controversial. Moreover, there is limited research evaluating the analytical sensitivity of other molecular detection kits. In this study, armored ribonucleic acid reference materials developed in-house were used to evaluate the analytical sensitivity of SARS-CoV-2 detection kits approved by the National Medical Products Administration. These were based on rRT-PCR and other molecular detection assays. The percentage retesting required with rRT-PCR kits was as follows: 0%, 7.69%, 15.38%, and 23.08% for samples with concentrations ranging from 50 000 to 781 copies/ml. In total, 93% of rRT-PCR kits had a LOD 1000 copies/ml. The LOD of other molecular detection kits ranged from 68 to 2264 copies/ml. The study findings can help pharmaceutical companies optimize and improve detection kits, guide laboratories in selecting kits, and assist medical workers in their daily work. Graphical Abstract [Display omitted] .
ISSN:1201-9712
1878-3511
DOI:10.1016/j.ijid.2021.08.043